Phase II Study of Ovulation in Obese Women
Conditions: Pregnancy Prevention Interventions: Drug: Levonorgestrel 0.15 milligram; Drug: Meloxicam 15 milligram; Other: calcium carbonate 750 milligram Sponsors: InnovaGyn, Inc.; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood
Conditions: Potassium (K) and Ionized Calcium (iCa) in Capillary Whole Blood Interventions: Diagnostic Test: Fingerstick blood draw Sponsors: Abbott Point of Care Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male Participants
Conditions: Heartburn; Indigestion; Stomach Acid Related Symptoms; Nocturnal Stomach Acid Related Symptoms; Healthy Volunteers Interventions: Drug: bi-layer calcium carbonate tablet (BAY1180654); Drug: Immediate release calcium carbonate tablet (BAY1180654) Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
A Single Arm Study Comparing ACC Supplement to CCS in Management of Hypoparathyroidism
Conditions: Hypoparathyroidism Interventions: Dietary Supplement: amorphous calcium carbonate Sponsors: Amorphical Ltd. Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Reduction of Dentine Hypersensitivity After Use of Different Dentifrices
Conditions: Sensitivity, Tooth Interventions: Drug: 5% CALCIUM SODIUM PHOSPHOSILICATE; Drug: 8% Arginine Sponsors: Armed Forces Institute of Dentistry, Pakistan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder
Conditions: Alcohol Use Disorder Interventions: Drug: Acamprosate calcium; Other: Placebo Sponsors: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Stimulan ® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study
Conditions: Diabete Mellitus; Foot Ulcer; Osteomyelitis - Foot; Surgical Procedure, Unspecified Interventions: Device: Calcium-sulphate granules with tobramicina+vancomicina Sponsors: Azienda Ospedaliero-Universitaria Careggi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery
Conditions: Colorectal Cancer Interventions: Drug: Nardraparin calcium injection Sponsors: RenJi Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Clinical Investigation of Effectiveness of a Calcium Silicate Cement
Conditions: Deep Caries; Dentin Caries Interventions: Device: Theracal (calcium silicate); Device: Dycal (calcium hydroxide) Sponsors: Hacettepe University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Effect of NanoChitosan Impregnated Calcium Hydroxide as an Intracanal Medication on Postoperative Pain Intensity and Bacterial Load Reduction
Conditions: Intervention Interventions: Combination Product: NanoChitosan impregnated Calcium Hydroxide Sponsors: Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
Conditions: Diabetes Mellitus, Type 2; Overweight Interventions: Drug: Exendin-4 Fc fusion protein (JY09) injection; Drug: Metformin Hydrochloride tablet; Drug: Rosuvastatin calcium tablets; Drug: Digoxin tablet Sponsors: Beijing Dongfang Biotech Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Conditions: Recurrent Acute Myeloid Leukemia; Recurrent Juvenile Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Acute Myeloid Leukemia; Refractory Myelodysplastic Syndrome Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Drug: Cytarabine; Procedure: Echocardiography; Drug: Fludarabine; Drug: Hydrocortisone Sodium Succinate; Biological: Imetelstat; Drug: Leucovorin Calcium; Procedure: Lumbar Puncture; Drug: Methotrexate Sponsors: Children ' s Oncology Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery
Conditions: Elective Cesarean Delivery Interventions: Drug: Calcium Gluconate 10%; Drug: sodium chloride 0.9% Sponsors: Rambam Health Care Campus Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
Conditions: Coronary Artery Disease Interventions: Device: Electronic health record-based notification of Nanox.AI Coronary Artery Calcification Assessment Sponsors: Brigham and Women ' s Hospital; Nano-X Imaging Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
Conditions: DMD-Associated Dilated Cardiomyopathy Interventions: Genetic: SRD-001 Sponsors: Sardocor Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
